COVID-19 in children across three Asian cosmopolitan regions

References

• WHO Coronavirus Disease (COVID-19) Dashboard; [cited 2020 Sep 4]. Available from: https://covid19.who.int/
   Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Leung GM, Cowling BJ, Wu JT. From a sprint to a marathon in Hong Kong. N Engl J Med. 2020 Apr 30;382(18):e45.
   PubMed Web of Science ®Google Scholar
• Hamer M, Gale CR, Kivimäki M, et al. Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom. Proc Natl Acad Sci U S A. 2020;117(35):21011.
   PubMed Web of Science ®Google Scholar
• Xiong XL, Wong KK, Chi SQ, et al. Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms. Gut. 2020 May 19. DOI:10.1136/gutjnl-2020-321486
   Web of Science ®Google Scholar
• Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4(9):653–661.
   PubMedGoogle Scholar
• Han MS, Choi EH, Chang SH, et al. Clinical Characteristics and Viral RNA Detection in Children With Coronavirus Disease 2019 in the Republic of Korea. JAMA Pediatr. 2020 Aug 28:e203988. DOI:10.1001/jamapediatrics.2020.3988
   Web of Science ®Google Scholar
• Park JY, Han MS, Park KU, et al. First pediatric case of coronavirus disease 2019 in Korea. J Korean Med Sci. 2020;35(11):e124–e124.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Huang Z, Ying G, et al. Study of the lymphocyte change between COVID-19 and non-COVID-19 pneumonia cases suggesting other factors besides uncontrolled inflammation contributed to multiorgan injury. medRxiv 2020. DOI:10.1101/2020.02.19.20024885
   Google Scholar
• Mak PQ, Chung KS, Wong JS, et al. Anosmia and ageusia: Not an uncommon presentation of COVID-19 infection in children and adolescents. Pediatr Infect Dis J. 2020;39(8):e199–e200.
   PubMed Web of Science ®Google Scholar
• Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020;58(3):299–301.
   PubMed Web of Science ®Google Scholar
• Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020 Sep;4(9):653–661.
   PubMedGoogle Scholar
• Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020: e20200702.
   PubMed Web of Science ®Google Scholar
• Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22(2):79–85.
   PubMed Web of Science ®Google Scholar
• Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020 Jun;10(6):537–540.
   PubMedGoogle Scholar
• Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. Br Med J. 2020;369:m2094.
   PubMed Web of Science ®Google Scholar
• Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607–1608.
   PubMed Web of Science ®Google Scholar
• Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771–1778.
   PubMed Web of Science ®Google Scholar
• Mavragani A. Tracking COVID-19 in Europe: Infodemiology Approach. JMIR Public Health Surveill. 2020;6(2):e18941.
   PubMedGoogle Scholar
• The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145–151.
   PubMedGoogle Scholar
• Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812-827.e19
   PubMed Web of Science ®Google Scholar
• Zhang L, Jackson CB, Mou H, et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv 2020. DOI:10.1101/2020.06.12.148726
   Google Scholar
• Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221–224.
   PubMed Web of Science ®Google Scholar
• Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA. 2020;323(23):2427–2429.
   PubMed Web of Science ®Google Scholar
• Chan KP. Control of severe acute respiratory syndrome in Singapore. Environ Health Prev Med. 2005;10(5):255–259.
   PubMedGoogle Scholar
• Xiong X, Chua GT, Chi S, et al. A comparison between Chinese children infected with coronavirus disease-2019 and with severe acute respiratory syndrome 2003. J Pediatr. 2020;224:30–36.
   PubMed Web of Science ®Google Scholar
• Lee PP, Wong WH, Leung GM, et al. Risk-stratified seroprevalence of severe acute respiratory syndrome coronavirus among children in Hong Kong. Pediatrics. 2006;117(6):e1156–e1162.
   PubMed Web of Science ®Google Scholar
• Cowling BJ, Ali ST, Ng TWY, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020;5(5):e279–e288.
   PubMed Web of Science ®Google Scholar
• Eastin C, Eastin T. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. J Emerg Med. 2020;58(4):712–713.
   Google Scholar